US Patent 11236335 Selective antisense compounds and uses thereof
Patent 11236335 was granted and assigned to Ionis Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11236335 Selective antisense compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
